Assessment of Drug Therapy in Pharmacy Practice and Therapeutics
VerifiedAdded on  2023/01/07
|5
|703
|73
Report
AI Summary
This report provides a critical assessment of drug therapy for a 61-year-old male patient presenting with crushing chest pain, hypertension, and other related health issues. The patient's medication regimen, including gemfibrozil, atenolol, glyceryl trinitrate, simvastatin, perindopril, valsartan, and diltiazem, is evaluated for its effectiveness in managing the patient's symptoms and reducing future health risks. The report emphasizes the importance of reviewing medications to optimize patient health outcomes and prevent adverse effects. It discusses the role of diltiazem, a calcium channel blocker, in treating hypertension and chest pain, highlighting its side effects and the need for blood pressure monitoring. Furthermore, the report outlines the initial steps a doctor should take, including performing an echocardiogram to assess the patient's heart condition and encouraging lifestyle changes such as smoking cessation. The references include relevant books and journal articles supporting the analysis.
1 out of 5











